AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CDCP recommends pneumococcal polysaccharide vaccine for adults older than 65.
2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDCP) recommends pneumococcal polysaccharide vaccination for all adults 65 years and older.
"Streptococcus pneumoniae remains the most common cause of community-acquired pneumonia and bacterial meningitis in older adults. Current recommendations from CDCP's Advisory Committee on Immunization Practices suggest providing pneumococcal polysaccharide vaccine to all adults age 65 and older and to persons age 2 to 64 with chronic illnesses that place them at higher risk for pneumococcal disease," scientists in the United States report.
"In addition, vaccination status should be assessed for residents of nursing homes and long-term care facilities on admission and vaccine administered as needed," said Cynthia G. Whitney at the CDCP. "Although the polysaccharide vaccine is safe, effective against invasive disease, and cost-effective, many older adults have not yet received the vaccine. Use of standing orders is encouraged as a ...
- Efficacy of pneumococcal polysaccharide vaccine/The commentators respond
- Magazine article from: Canadian Medical Association. Journal Scott, Pippa; Huss, Anke; Stuck, Andreas E; Trotter, Caroline; Egger, Matthias; Andrews, Ross M; Moberley, Sarah A May 26, 2009 700+ words
...the efficacy of pneumococcal polysaccharide vaccine,1 Ross Andrews...introduction of pneumococcal polysaccharide vaccine in resource-limited...think that the pneumococcal polysaccharide vaccine is the answer...
- CDCP recommends pneumococcal polysaccharide vaccine for adults older than 65.
- Newspaper article from: Medical Letter on the CDC & FDA December 7, 2003 700+ words
...CDCP) recommends pneumococcal polysaccharide vaccination for all...suggest providing pneumococcal polysaccharide vaccine to all adults age...ACIP recommends pneumococcal polysaccharide vaccine for all adults age...
- Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children...
- Magazine article from: Emerging Infectious Diseases Fiore, Anthony E. Levine, Orin S. Elliott, John A. Facklam, Richard R. Butler, Jay C. November 1, 1999 700+ words
...the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates...immunogenicity of the polysaccharide vaccine, scant data exist...Clinical trials of pneumococcal polysaccharide vaccine effectiveness in children...
- A Flow Cytometric Opsonophagocytic Assay for Measurement of Functional...
- Newspaper article from: Vaccine Weekly August 30, 1999 700+ words
...With the 23-Valent Pneumococcal Polysaccharide Vaccine." Clinical and...either heterologous pneumococcal polysaccharide or penicillin in...with the 23-valent pneumococcal polysaccharide vaccine. When compared with...
- Pneumococcal polysaccharide vaccine has limited efficacy in...
- Magazine article from: JAAPA-Journal of the American Academy of Physicians Assistants April 1, 2009 700+ words
Clinical question Is the pneumococcal polysaccharide vaccine (PPV) effective for adults? Bottom line The evidence to support the efficacy of PPV in adults is limited at best. The best...
- Safety of Revaccination with Pneumococcal Polysaccharide Vaccine.
- Magazine article from: Internal Medicine Alert Kuritzky, Louis March 29, 1999 700+ words
SINCE POST-VACCINATION ANTIBODY levels as well as protective efficacy of pneumococcal vaccine decline over time, revaccination after five years or more is recommended for immunocompromised persons and people older than 65 who were vaccinated before the age of 65. Implementation of these
- Wyeth Ceases Production of Its Injectable Influenza Vaccine and Pneumococcal...
- Press release article from: PR Newswire November 19, 2002 700+ words
- Company to Stop Manufacturing FluShield(R) and Pnu-Imune(R) Vaccines - Wyeth announced today that it is ceasing production of two of its vaccine products -- FluShield (R), an injectable influenza virus vaccine and Pnu-Imune(R), an injectable polysaccharide pneumococcal vaccine for adults.
- Pneumococcal Polysaccharide Antigens Upregulate Immune Response In...
- Newspaper article from: Vaccine Weekly May 16, 2001 700+ words
...staff medical writer - Pneumococcal polysaccharide antigens increase CD40...to determine whether pneumococcal polysaccharide antigens induce mRNA...with the 23-valent pneumococcal polysaccharide vaccine induces changes in...